期刊文献+

铝镁加联合艾普拉唑治疗反流性食管炎的临床疗效观察 被引量:1

下载PDF
导出
摘要 目的观察铝镁加联合艾普拉唑治疗反流性食管炎的临床疗效。方法经内镜下确诊反流性食管炎患者64例,随机分为观察组与对照组。两组均口服艾普拉唑和吗丁啉,其中观察组加用铝镁加。疗程均为8周。对比观察临床有效率、胃镜下愈合率和不良反应,以及1年后随访结果。结果临床症状缓解时间和总有效率观察组分别为(8.46±3.34)d、96.88%,显著优于对照组的(16.56±5.65)d和78.12%(P<0.05);内镜下食管炎疗效总有效率观察组为93.75%、显著高于对照组的75.00%(P<0.05);1年复发率观察组为9.38%,显著优于对照组的18.15%(P<0.05);两组无严重不良反应发生。结论铝镁加联合艾普拉唑治疗反流性食管炎有更好的近期疗效和较低的复发率。
作者 郭永辉
出处 《中国医药指南》 2011年第24期252-253,共2页 Guide of China Medicine
  • 相关文献

参考文献9

  • 1Kristina Anderson BA.Gastroesophageal reflux disease[J].Radiol Technol,2010,81(3):251-268.
  • 2雷贝拉唑多中心临床协作组.反流性食管炎患者的症状特征及雷贝拉唑治疗疗效的多中心评估[J].中华消化杂志,2005,25(6):363-365. 被引量:61
  • 3Chung SJ,Kim SG,Jung HC,et al.Kim JS.Clinical practice patterns of gastroenterologists for initial and maintenance therapy in gastroesophageal reflux disease:a nationwide online survey in Korea[J].Korean J Gastroenterol,.2009,54(6):364-370.
  • 4Yasuhara H,Miyake Y,Toyokawa T,et al.Large Waist Circumference Is a Risk Factor for Reflux Esophagitis in Japanese Males[J].Digestion,2010,81(3):181-187.
  • 5陆星华,张泰昌.反流性食管炎诊断及治疗指南(2003年)[J].中华消化内镜杂志,2004,21(4):221-222. 被引量:842
  • 6DE Vault KR,Castell DO.The practice parameters committee of the American college of gastroenterology.Updated guidelines for the diagnosisand treatment of gastroesophageal reflux disease[J].Am J Gastroenterol,1999,94(6):1434-1442.
  • 7Dickman R,Bautista JM,WongWM,et al.Comparison of esophageal acid exposure distribution along the esophagus among the different gastroesophageal reflux disease (GERD) groups[J].Am J Gastroe nterol,2006,101(11):2463-2469.
  • 8Talaie R,ForootanM,Donboli K,et al.24-hour ambulatory pH-metry in patients with refractory heartburn:a prospective study[J].J Gastrointestin Liver Dis,2009,18(1):11-15.
  • 9刘腾,常艳璐,韩容.艾普拉唑的作用机制与临床评价[J].中国医院用药评价与分析,2009,9(10):724-725. 被引量:38

二级参考文献15

  • 1雷贝拉唑多中心临床观察协作组.雷贝拉唑对胃溃疡患者胃内pH值的影响[J].中华内科杂志,2004,43(9):675-678. 被引量:39
  • 2Kwon D, Chae JB, Park CW, et al.Effects of IY - 81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo [ J ]. Arzneimittelforschung, 2001,51 (3) :204.
  • 3Kim E J, Lee RK, Lee SM, et al. General pharmacology of IY - 81149, a new proton pump inhibitor [ J ]. Arzneimittelforschung , 2001,51 ( 1 ) : 51.
  • 4Kil BJ, Kim IW, Shin CY, et al. Comparison of IY81149 with omeprazole in rat reflux oesophagitis [ J ], Auton Pharmacol, 2000,20(5 - 6) :291.
  • 5Periclou AP, Goldwater R, Lee SM, et al. A comparative pharmacodynamic study of IY- 81149 versus omeprazole in patients with gastroesophageal reflux disease [ J ]. Clin Pharmacol Ther, 2000,68 (3) : 304.
  • 6Ho KY, Kuan A, Zano F, et al. Randomized, parallel, double - blind comparison of the ulcer- healing effects of ilaprazole and omeprazole in the treatment of gastric and duodenal ulcers[J] . J Gastroenterol, 2009,44(7) :697.
  • 7Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: Incidence and precipitating factors. Am J Dig Dis, 1976,21:953-956.
  • 8Pan GZ, Xu GM, Ke MY, et al. Epidemiological study of symptomatic gastroesophageal reflux disease in China: Beijing and Shanghai. Chin J Dig Dis ,2000, 1:2-8.
  • 9Williams MP, Sercombe J, Hamilton MI, et al. A placebocontrolled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects.Aliment Pharmacol Ther, 1998,12:1079-1089.
  • 10Ishizaki T, Horai Y. Review article: cytochrome P450 and the metabolism of proton pump inhibitors-emphasis on rabeprazole.Aliment Pharmacol Ther , 1999,13(suppl 3): 27-36.

共引文献925

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部